NICOLE JUNKERMANN

 

Owkin have announced that they have received a $180 million investment from Sanofi, the global pharmaceutical company.

They have also been awarded four exclusive collaborative cancer research projects, worth $90 million.

Owkin have now officially reached UNICORN status!